205 related articles for article (PubMed ID: 30770797)
21. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
Gaudio E; Paduano F; Ngankeu A; Ortuso F; Lovat F; Pinton S; D'Agostino S; Zanesi N; Aqeilan RI; Campiglia P; Novellino E; Alcaro S; Croce CM; Trapasso F
Oncotarget; 2016 May; 7(21):29927-36. PubMed ID: 27166255
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines.
Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA
Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097
[TBL] [Abstract][Full Text] [Related]
24. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.
Roz L; Gramegna M; Ishii H; Croce CM; Sozzi G
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3615-20. PubMed ID: 11891319
[TBL] [Abstract][Full Text] [Related]
25. Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel.
Gaudio E; Paduano F; Spizzo R; Ngankeu A; Zanesi N; Gaspari M; Ortuso F; Lovat F; Rock J; Hill GA; Kaou M; Cuda G; Aqeilan RI; Alcaro S; Croce CM; Trapasso F
PLoS One; 2013; 8(11):e78610. PubMed ID: 24223161
[TBL] [Abstract][Full Text] [Related]
26. FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells.
Bianchi F; Magnifico A; Olgiati C; Zanesi N; Pekarsky Y; Tagliabue E; Croce CM; Ménard S; Campiglio M
Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18981-6. PubMed ID: 17142325
[TBL] [Abstract][Full Text] [Related]
27. BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells.
Cheng MH; Huang HL; Lin YY; Tsui KH; Chen PC; Cheng SY; Chong IW; Sung PJ; Tai MH; Wen ZH; Chen NF; Kuo HM
Oxid Med Cell Longev; 2019; 2019():6342104. PubMed ID: 31205586
[TBL] [Abstract][Full Text] [Related]
28. Aberrant FHIT expression is linked to bladder carcinogenesis and apoptosis.
Han Y; Zhang Z; Zhang GJ; Guo KF; Shan GY; Kong CZ
Asian Pac J Cancer Prev; 2011; 12(11):2915-20. PubMed ID: 22393963
[TBL] [Abstract][Full Text] [Related]
29. Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells.
Joannes A; Grelet S; Duca L; Gilles C; Kileztky C; Dalstein V; Birembaut P; Polette M; Nawrocki-Raby B
Mol Cancer Res; 2014 May; 12(5):775-83. PubMed ID: 24464917
[TBL] [Abstract][Full Text] [Related]
30. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
Song X; Tian Z; Wang S; Peng Z; Feng J
Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
[TBL] [Abstract][Full Text] [Related]
31. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
32. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
[TBL] [Abstract][Full Text] [Related]
33. Fhit loss-associated initiation and progression of neoplasia in vitro.
Karras JR; Schrock MS; Batar B; Zhang J; La Perle K; Druck T; Huebner K
Cancer Sci; 2016 Nov; 107(11):1590-1598. PubMed ID: 27513973
[TBL] [Abstract][Full Text] [Related]
34. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Ishii H; Vecchione A; Fong LY; Zanesi N; Trapasso F; Furukawa Y; Baffa R; Huebner K; Croce CM
Curr Gene Ther; 2004 Mar; 4(1):53-63. PubMed ID: 15032614
[TBL] [Abstract][Full Text] [Related]
35. Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line.
Cavazzoni A; Galetti M; Fumarola C; Alfieri RR; Roz L; Andriani F; Carbognani P; Rusca M; Sozzi G; Petronini PG
Cancer Lett; 2007 Feb; 246(1-2):69-81. PubMed ID: 16616810
[TBL] [Abstract][Full Text] [Related]
36. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
37. A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.
Boylston JA; Brenner C
Cell Cycle; 2014; 13(18):2913-30. PubMed ID: 25486479
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the role of Fhit in suppression of DNA damage.
Saldivar JC; Bene J; Hosseini SA; Miuma S; Horton S; Heerema NA; Huebner K
Adv Biol Regul; 2013 Jan; 53(1):77-85. PubMed ID: 23102829
[TBL] [Abstract][Full Text] [Related]
39. FHIT
Da Silva J; Jouida A; Ancel J; Dalstein V; Routhier J; Delepine G; Cutrona J; Jonquet A; Dewolf M; Birembaut P; Deslée G; Polette M; Nawrocki-Raby B
J Pathol; 2020 Jun; 251(2):187-199. PubMed ID: 32237123
[TBL] [Abstract][Full Text] [Related]
40. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
